by TractManager | Jan 12, 2022 | News
On January 11, 2022, the Centers for Medicare and Medicaid Services (CMS) released a proposed decision memo, Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease, proposing to cover FDA-approved monoclonal antibodies directed against...
by TractManager | Jan 12, 2022 | Clinical Utility Evaluation
This report evaluates the clinical utility of pharmacogenomic testing to inform the selection or dose of medications for individuals diagnosed with attention-deficit/hyperactivity disorder (ADHD) to improve clinical outcomes.If you have a Hayes login, click here to...
by TractManager | Jan 11, 2022 | Precision Medicine Insights
This report reviews clinical study abstracts and clinical practice guidelines addressing comprehensive molecular profiling (CMP) tests for the intended use as a broad molecular profiling tool (assessing DNA or RNA variants in > 50 genes), to identify biomarkers...
by TractManager | Jan 10, 2022 | Publications
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Tenex (Tenex Health TX) to administer percutaneous ultrasonic tenotomy to reduce pain and improve quality of life...
by TractManager | Jan 5, 2022 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Cala Trio (Cala Health Inc.) for treatment of essential tremor.If you have a Hayes login, click here to view the...
Recent Comments